Progeria epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(→Age) |
|||
| Line 20: | Line 20: | ||
*Patients of all age groups may develop [disease name]. | *Patients of all age groups may develop [disease name]. | ||
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years. | *The incidence of [disease name] increases with age; the median age at diagnosis is [#] years. | ||
* | *Hutchinson-Gilford progeria syndrome (HGPS) commonly affects individuals of very younger age rather than older age. | ||
*The median age at diagnosis is 2.9 years overall.<ref name="pmid168383304">{{cite journal| author=Hennekam RC| title=Hutchinson-Gilford progeria syndrome: review of the phenotype. | journal=Am J Med Genet A | year= 2006 | volume= 140 | issue= 23 | pages= 2603-24 | pmid=16838330 | doi=10.1002/ajmg.a.31346 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16838330 }}</ref> | |||
*[Chronic disease name] is usually first diagnosed among [age group]. | *[Chronic disease name] is usually first diagnosed among [age group]. | ||
*[Acute disease name] commonly affects [age group]. | *[Acute disease name] commonly affects [age group]. | ||
Revision as of 20:28, 16 July 2019
|
Progeria Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Progeria epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Progeria epidemiology and demographics |
|
Risk calculators and risk factors for Progeria epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Incidence
- The incidence of Hutchinson-Gilford progeria syndrome (HGPS) is approximately one in four to eight million births worldwide.[1]
- The incidence of Hutchinson-Gilford progeria syndrome (HGPS) in Netherlands is 1:4,000,000.[2]
Prevalence
- The prevalence of Hutchinson-Gilford progeria syndrome (HGPS) is approximately 1 in 20 million individuals worldwide.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- Hutchinson-Gilford progeria syndrome (HGPS) commonly affects individuals of very younger age rather than older age.
- The median age at diagnosis is 2.9 years overall.[3]
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- Hutchinson-Gilford progeria syndrome (HGPS) affects men and women equally but males are little more commonly affected by Hutchinson-Gilford progeria syndrome (HGPS) than females. The male to female ratio is approximately 1.2:1.[4]
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Hennekam RC (2006). "Hutchinson-Gilford progeria syndrome: review of the phenotype". Am J Med Genet A. 140 (23): 2603–24. doi:10.1002/ajmg.a.31346. PMID 16838330.
- ↑ Hennekam RC (2006). "Hutchinson-Gilford progeria syndrome: review of the phenotype". Am J Med Genet A. 140 (23): 2603–24. doi:10.1002/ajmg.a.31346. PMID 16838330.
- ↑ Hennekam RC (2006). "Hutchinson-Gilford progeria syndrome: review of the phenotype". Am J Med Genet A. 140 (23): 2603–24. doi:10.1002/ajmg.a.31346. PMID 16838330.
- ↑ Hennekam RC (2006). "Hutchinson-Gilford progeria syndrome: review of the phenotype". Am J Med Genet A. 140 (23): 2603–24. doi:10.1002/ajmg.a.31346. PMID 16838330.